Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.170
+0.020 (1.74%)
At close: Oct 27, 2026, 4:00 PM EDT
1.150
-0.020 (-1.71%)
After-hours: Oct 27, 2026, 7:30 PM EDT
Gain Therapeutics Employees
As of December 31, 2025, Gain Therapeutics had 21 total employees, including 20 full-time and 1 part-time employees. The number of employees decreased by 4 or 16.00% compared to the previous year. That makes Gain Therapeutics the 38,166th largest employer in the world and 5,464th in the United States.
Employees
21
Change (1Y)
-4
Growth (1Y)
-16.00%
Revenue / Employee
n/a
Profits / Employee
-$957,441
Market Cap
51.06M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | -4 | -16.00% | 20 | 1 |
| Dec 31, 2024 | 25 | -7 | -21.88% | 23 | 2 |
| Dec 31, 2023 | 32 | 1 | 3.23% | 29 | 3 |
| Dec 31, 2022 | 31 | 2 | 6.90% | 28 | 3 |
| Dec 31, 2021 | 29 | 15 | 107.14% | 25 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caribou Biosciences | 97 |
| Alps Group | 93 |
| MindWalk Holdings | 77 |
| Xilio Therapeutics | 76 |
| Connect Biopharma Holdings | 64 |
| Pliant Therapeutics | 49 |
| Elicio Therapeutics | 33 |
| iBio, Inc. | 23 |
GANX News
- 14 days ago - Sibylla Biotech Appoints Usman Azam CEO, Gianluca Fuggetta CFO, and Expands Executive Team to Drive Transition to Clinic - GlobeNewsWire
- 19 days ago - Gain Therapeutics to Attend the 2026 Maxim Growth Summit - GlobeNewsWire
- 26 days ago - Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration - GlobeNewsWire
- 4 weeks ago - Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson's Disease and Movement Disorders - GlobeNewsWire
- 5 weeks ago - Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference - GlobeNewsWire
- 2 months ago - Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Gain Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - Gain Therapeutics Quarterly report: Q2 2026 - Filings